Making Sense of Differing Guidelines for Clostridioides difficile Infection
Infectious Disease Clinics of North America · 2025
DOI: 10.1016/j.idc.2025.07.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infectious Disease Clinics of North America, 2025. Verfasst von Kanika Sehgal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA. Hauptthemen laut MEDLINE: Clostridium Infections, Clostridioides difficile, Practice Guidelines as Topic. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Leeds Biomedical Research Centre, National Institute for Health and Care Research.
Abstract (Originalsprache)
The Clostridioides difficile infection (CDI) epidemic has been impacting the world for years. Understanding accurate diagnostics is imperative to allow the appropriate patients to be treated and improve outcomes. This article leverages multiple global societal guidelines to focus on the evolving diagnostic tests available summarizing best diagnostic practices including 2-step diagnostic testing. Therapeutically, guideline recommendations more recently have favored fidaxomicin and incorporated immune-based therapies and microbial restoration therapies. As treatment options and guideline recommendations change, it is imperative to understand why these recommendations have evolved and understand current best diagnostic and therapeutic practices in managing CDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.
- Department of Digestive Diseases, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; Department of Gastroenterology, PACT Gastroenterology Center, 2200 Whitney Avenue, Hamden, CT 06518, USA. Electronic…
- Leeds Institute of Medical Research, Leeds Teaching Hospitals, University of Leeds, Leeds Ls1 3EX, UK.
Förderung
- Leeds Biomedical Research Centre
- National Institute for Health and Care Research
Zitieren
APA
Sehgal, K., Feuerstadt, P., & Wilcox, M. H. (2025). Making Sense of Differing Guidelines for Clostridioides difficile Infection. Infectious Disease Clinics of North America. https://doi.org/10.1016/j.idc.2025.07.010
Vancouver
Sehgal K, Feuerstadt P, Wilcox MH. Making Sense of Differing Guidelines for Clostridioides difficile Infection. Infectious Disease Clinics of North America. 2025. doi:10.1016/j.idc.2025.07.010
BibTeX
@article{Sehgal2025,
author = {Sehgal, Kanika and Feuerstadt, Paul and Wilcox, Mark H},
title = {Making Sense of Differing Guidelines for Clostridioides difficile Infection},
journal = {Infectious Disease Clinics of North America},
year = {2025},
doi = {10.1016/j.idc.2025.07.010}
}
EUVIMED